These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36278778)

  • 1. House dust mite allergen immunotherapy for monosensitized versus polysensitized patients with allergic rhinitis: A systematic review and meta-analysis.
    Phinyo P; Krikeerati T; Wongyikul P; Lao-Araya M; Thongngarm T
    Asian Pac J Allergy Immunol; 2022 Dec; 40(4):337-352. PubMed ID: 36278778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Efficacy and Safety of Subcutaneous Immunotherapy in Monosensitized and Polysensitized Children With Allergic Rhinitis.
    Yuan X; Xie S; Zhang H; Zhang J; Fan R; Jiang W; Xie Z
    Otolaryngol Head Neck Surg; 2024 Mar; 170(3):919-927. PubMed ID: 38104318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy tablets in monosensitized and polysensitized adults with allergic rhinoconjunctivitis.
    Nelson HS; Bernstein DI; Biedermann T; Nolte H
    Allergy Asthma Proc; 2024 Jan; 45(1):33-36. PubMed ID: 38151733
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancing quality of life with 3-year course of sublingual immunotherapy for house dust mite-induced allergic rhinitis: An observational prospective study in real-life settings.
    Zhang Y; Li J; Long Y; Ling Z
    Am J Otolaryngol; 2024; 45(5):104418. PubMed ID: 39067091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
    Huang HH; Xu C; Liu L; Chai RN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study.
    Cui L; Li J; Li Y; Xia Z
    Int Arch Allergy Immunol; 2019; 180(2):144-149. PubMed ID: 31256165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases.
    Li P; Li Q; Huang Z; Chen W; Lu Y; Tian M
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):796-801. PubMed ID: 25145986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of sublingual dust mite drops in children with mono- or polysensitized allergic rhinitis.
    Zhang YZ; Luo J; Wang ZH; Wang J
    Am J Otolaryngol; 2019; 40(5):755-760. PubMed ID: 31327579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Efficacy and Safety of Artesimia annua-Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time.
    Yang J; Shen Z; Liu L; Kang W; Shao Y; Zhang P; Quan F
    Int Arch Allergy Immunol; 2022; 183(8):852-859. PubMed ID: 35413714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic modification in mono- and poly-sensitized patients after sublingual immunotherapy.
    Kim JY; Han DH; Won TB; Kim HJ; Lee CH; Rhee CS; Kim DY
    Laryngoscope; 2019 May; 129(5):E170-E177. PubMed ID: 30548878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Cohort Study of Sublingual Immunotherapy with Standardized Dermatophagoides farinae Drops for Allergic Rhinitis.
    Ma X; Zhang Y; Gu X; Wu G; Liu J; Lu J; Yang H
    Adv Ther; 2021 May; 38(5):2315-2322. PubMed ID: 33740216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of sublingual immunotherapy with Dermatophagoides farina drops in monosensitized and polysensitized children with allergic rhinitis and asthma].
    Xing QB; Chen S; Chen B; Li HF; Chen LL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(3):204-208. PubMed ID: 29871223
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of sublingual immunotherapy on patients with allergic rhinitis].
    Yang J; Jiang H; Xiang YL; Wu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 34(1):53-56. PubMed ID: 32086899
    [No Abstract]   [Full Text] [Related]  

  • 14. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy in one-year treatment with Artemisia annua-SLIT drops in monosensitized and polysensitized individuals.
    Shen Z; Zhang P; Kang W; Chen X; Li H; Shao Y; Liu L; Quan F
    Am J Otolaryngol; 2023; 44(6):104002. PubMed ID: 37478537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis.
    Zhao L; Zhang Y; Zhang S; Zhang L; Lan F
    Expert Rev Clin Immunol; 2021 Sep; 17(9):969-975. PubMed ID: 34388949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in monosensitized and polysensitized patients with allergic rhinitis].
    Chen BY; Long ZM; Huang YJ; Zeng JM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 48(7):549-54. PubMed ID: 24313202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma.
    Zhang P; Jia Y; Jing Z; Huang J; Wu H; Sun X
    Pulm Pharmacol Ther; 2023 Feb; 78():102187. PubMed ID: 36603742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.